Fosravuconazole, an oral medication introduced in 2018, showed an increasing trend, coinciding with a decline in efinaconazole prescriptions.
← all excerpts
Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study.
1
—
—